The Immunoassay Market is expected to be around US$ 43.60 Billion by 2028 at a CAGR of 6.5% in the given forecast period.
The rising number of individuals suffering from chronic and infectious diseases represents one of the significant factors propelling the immunoassay market growth. As IA provides inherent specificity, high-throughput, and high sensitivity for the analysis of biological samples, it is utilized in disease diagnosis, clinical pharmacokinetics, therapeutic drug monitoring, and drug discovery across the world. In addition to this, the automation, versatility, and the speed of analysis, coupled with the stringent regulatory framework regarding the food safety, is fueling the demand for immunoassay in food testing. Moreover, the rising trend of smartphone-based formats and multiplex bead assays is projected to propel the demand for IAs for managing health issues in real-time and allowing in vitro diagnostics.
The global Immunoassay market is segregated on the basis of Technology as ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT and PCR. Based on Product & Service the global Immunoassay market is segmented in Reagents & Kits, Analyzers and Software Services. Based on Application the global Immunoassay market is segmented in Infectious Disease, Endocrinology, Cardiology, Oncology and Hematology.
Based on End User, the global Immunoassay market is segmented in Hospitals, Clinical Laboratories, Blood Banks, Academic Research Centers, Pharmaceutical Companies, Biotechnology Companies and Others.
The global Immunoassay market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Immunoassay market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Abbott Diagnostics, Abcam, Arlington Scientific, Arrayit Corporation, Autobio Diagnostics, Awareness Technology, Beckman Coulter Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocartis, Biomatik, bioMerieux Diagnostics, Bioneer Corporation, BioTek Instruments, Boditech Med, Inc, and others are among the major players in the global Immunoassay market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Immunoassay Market has been segmented as below:
Immunoassay Market, By Technology
Immunoassay Market, By Product & Service
Immunoassay Market, By Application
Immunoassay Market, By End User
Immunoassay Market, By Region
Immunoassay Market, By Company
The report covers:
Report Scope:
The global Immunoassay market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Immunoassay market share. Major industry players with significant revenue share include Abbott Diagnostics, Abcam, Arlington Scientific, Arrayit Corporation, Autobio Diagnostics, Awareness Technology, Beckman Coulter Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocartis, Biomatik, bioMerieux Diagnostics, Bioneer Corporation, BioTek Instruments, Boditech Med, Inc, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Breakthrough Therapy Drugs Market
Cellulose Ether & Its Derivatives Market
Cholesterol Screening/ Cholesterol Lab Testing Services Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter’s Five Force Analysis
5. Immunoassay Market, By Technology
5.1. Introduction
5.2. ELISA
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Fluorescence
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.4. Colorimetric
5.4.1. Market Overview
5.4.2. Market Size and Forecast
5.5. Chemiluminescence
5.5.1. Market Overview
5.5.2. Market Size and Forecast
5.6. Rapid Test
5.6.1. Market Overview
5.6.2. Market Size and Forecast
5.7. Western Blot
5.7.1. Market Overview
5.7.2. Market Size and Forecast
5.8. ELISPOT
5.8.1. Market Overview
5.8.2. Market Size and Forecast
5.9. PCR
5.9.1. Market Overview
5.9.2. Market Size and Forecast
6. Immunoassay Market, By Product & Service
6.1. Introduction
6.2. Reagents & Kits
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Analyzers
6.3.1. Market Overview
6.3.2. Market Size and Forecast
6.4. Software Services
6.4.1. Market Overview
6.4.2. Market Size and Forecast
7. Immunoassay Market, By Application
7.1. Introduction
7.2. Infectious Disease
7.2.1. Market Overview
7.2.2. Market Size and Forecast
7.3. Endocrinology
7.3.1. Market Overview
7.3.2. Market Size and Forecast
7.4. Cardiology
7.4.1. Market Overview
7.4.2. Market Size and Forecast
7.5. Oncology
7.5.1. Market Overview
7.5.2. Market Size and Forecast
7.6. Hematology
7.6.1. Market Overview
7.6.2. Market Size and Forecast
8. Immunoassay Market, By End User
8.1. Introduction
8.2. Hospitals
8.2.1. Market Overview
8.2.2. Market Size and Forecast
8.3. Clinical Laboratories
8.3.1. Market Overview
8.3.2. Market Size and Forecast
8.4. Blood Banks
8.4.1. Market Overview
8.4.2. Market Size and Forecast
8.5. Academic Research Centers
8.5.1. Market Overview
8.5.2. Market Size and Forecast
8.6. Pharmaceutical Companies
8.6.1. Market Overview
8.6.2. Market Size and Forecast
8.7. Biotechnology Companies
8.7.1. Market Overview
8.7.2. Market Size and Forecast
8.8. Others
8.8.1. Market Overview
8.8.2. Market Size and Forecast
9. Immunoassay Market, By Geography
9.1. Introduction
9.2. North America
9.2.1. North America Immunoassay, By Technology
9.2.2. North America Immunoassay, By Product & Service
9.2.3. North America Immunoassay, By Application
9.2.4. North America Immunoassay, By End User
9.3. Europe
9.3.1. Europe Immunoassay, By Technology
9.3.2. Europe Immunoassay, By Product & Service
9.3.3. Europe Immunoassay, By Application
9.3.4. Europe Immunoassay, By End User
9.4. Asia-Pacific
9.4.1. Asia-Pacific Immunoassay, By Technology
9.4.2. Asia-Pacific Immunoassay, By Product & Service
9.4.3. Asia-Pacific Immunoassay, By Application
9.4.4. Asia-Pacific Immunoassay, By End User
9.5. Rest of the World
9.5.1. Rest of the World Immunoassay, By Technology
9.5.2. Rest of the World Immunoassay, By Product & Service
9.5.3. Rest of the World Immunoassay, By Application
9.5.4. Rest of the World Immunoassay, By End User
10. Competitive Insights
10.1. Key Insights
10.2. Company Market Share Analysis
10.3. Strategic Outlook
10.3.1. Mergers & Acquisitions
10.3.2. New Product Developments
10.3.3. Portfolio/Production Capacity Expansions
10.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5. Others
11. Company Profiles
11.1. Abbott Diagnostics
11.1.1. Company Overview
11.1.2. Product/Service Landscape
11.1.3. Financial Overview
11.1.4. Recent Developments
11.2. Abcam
11.2.1. Company Overview
11.2.2. Product/Service Landscape
11.2.3. Financial Overview
11.2.4. Recent Developments
11.3. Arlington Scientific
11.3.1. Company Overview
11.3.2. Product/Service Landscape
11.3.3. Financial Overview
11.3.4. Recent Developments
11.4. Arrayit Corporation
11.4.1. Company Overview
11.4.2. Product/Service Landscape
11.4.3. Financial Overview
11.4.4. Recent Developments
11.5. Autobio Diagnostics
11.5.1. Company Overview
11.5.2. Product/Service Landscape
11.5.3. Financial Overview
11.5.4. Recent Developments
11.6. Awareness Technology
11.6.1. Company Overview
11.6.2. Product/Service Landscape
11.6.3. Financial Overview
11.6.4. Recent Developments
11.7. Beckman Coulter Diagnostics
11.7.1. Company Overview
11.7.2. Product/Service Landscape
11.7.3. Financial Overview
11.7.4. Recent Developments
11.8. Becton, Dickinson and Company
11.8.1. Company Overview
11.8.2. Product/Service Landscape
11.8.3. Financial Overview
11.8.4. Recent Developments
11.9. Bio-Rad Laboratories, Inc.
11.9.1. Company Overview
11.9.2. Product/Service Landscape
11.9.3. Financial Overview
11.9.4. Recent Developments
11.10. Biocartis
11.10.1. Company Overview
11.10.2. Product/Service Landscape
11.10.3. Financial Overview
11.10.4. Recent Developments
11.11. Biomatik
11.11.1. Company Overview
11.11.2. Product/Service Landscape
11.11.3. Financial Overview
11.11.4. Recent Developments
11.12. bioMerieux Diagnostics
11.12.1. Company Overview
11.12.2. Product/Service Landscape
11.12.3. Financial Overview
11.12.4. Recent Developments
11.13. Bioneer Corporation
11.13.1. Company Overview
11.13.2. Product/Service Landscape
11.13.3. Financial Overview
11.13.4. Recent Developments
11.14. BioTek Instruments
11.14.1. Company Overview
11.14.2. Product/Service Landscape
11.14.3. Financial Overview
11.14.4. Recent Developments
11.15. Boditech Med, Inc
11.15.1. Company Overview
11.15.2. Product/Service Landscape
11.15.3. Financial Overview
11.15.4. Recent Developments
The Immunoassay Market has been segmented as below:
Immunoassay Market, By Technology
Immunoassay Market, By Product & Service
Immunoassay Market, By Application
Immunoassay Market, By End User
Immunoassay Market, By Region
Immunoassay Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
